MUDr. Tomáš Páleníček, Ph.D.
researcher, physician, lecturer, research assistant
working at:  RP1 Experimental Neurobiology
Medical care: Neurophysiology and EEG
RP6 Brain Electrophysiology
v instituci:  2001 - present
telephone: (+420) 283 088 454
e-mail: tomas.palenicek@nudz.cz


Dr. Palenicek has been employed at National Institute of Mental Health, Czech Republic (NIHM CR, formerly Prague Psychiatric Centre) since 2001. He started his career as a PhD student in preclinical research, studying the neurobiology of schizophrenia in animal models. Shortly after, he received his first grant funding and extended his research interests towards the neurobiology of psychedelic drugs (e.g., LSD, psilocin, mescaline, 2C-B), entactogens (ecstasy / MDMA) and new synthetic drugs. Simultaneous to working on his PhD he passed his training as a clinical psychiatrist with a specialism in clinical electroencephalography (EEG). He defended his thesis in early 2009 and in 2012 he became a licensed psychiatrist. Over the last few years he contributes significantly to human clinical research. He is involved as a co-investigator of ketamine projects in NIHM CR, where ketamine is used to model psychosis and to treat depression in humans. For the last four  years he is a principle investigator of the first project in the Czech Republic that is intended to study the acute effects of cannabis in healthy volunteers. Finally, he is also a principle investigator of the first human clinical trial in the Czech Republic studying the effects of psilocybin in human volunteers. Currently his research interests are oriented to the area of EEG functional connectivity. He  continues his clinical practice as a psychiatrist in local outpatient clinic.

Professional training and experience

1995 - 1997: Contact worker at the Contact Center for addicts (SANANIM)
1998 - 2001: Passing out the accredited group dynamic psychotherapeutic training SUR
1999 - 2000: Somatic and social consequences of drug use (superviser J. Pachl, MD, CSc.)
2000 - 2001: Research of neurobiological mechanisms of drug addiction using microdialysis in freely moving animals (supervisor Pharm.Dr. M. Fišerová, CSc.)
2001 - 2009: Postgradual studies (Ph.D.) in neurosciences ( 3rd Medical Faculty, Charles Univ, supervisor Prof. C. Höschl, DrSc.)
2001 - present: scientist at Prague psychiatric Center
2005: First Certificate in English (FCE)
2006: passing out the training allowing to work with altered states of consciousness (Stargate)
2006 - present: psychiatrist at Prague Psychiatric Center
2010: certification in electroencefalography (Clinical neurophysiology society and Neurological Society ČLS JEP)
2010 - present: certification in electroencefalography (Clinical neurophysiology society and Neurological Society ČLS JEP)

Membership in professional organizations

2003 - present: member of Czech Neuropsychopharmacological Association
2006 - present: Erowid.org member
2010 - present: member of International Pharmaco-EEG Group (IPEG)
2014 - present: member of European College of Neuropsychopharmacology (ECNP)
2014 - present: member of The International College of Neuropsychopharmacology (CINP)

Awards and honors

2008: ČNPS award for best poster presentation in the research field “Psychedelics” (50th Czech-Slovak psychopharmacological conference in Jeseník Spa in 9th -13th January 2008): Fujáková M., Rohanová M., Kutová M., Páleníček T., Balíková M., Brunovský M. Tišlerová B., Šóš P., Bubeníková-Valešová V. Farmakokinetika, behaviorální a QEEG účinky syntetického psychedelika 2C-B.
2009: Prof. Werner M. Herrmann Memorial Grant od International Pharmaco - EEG society (IPEG) for best poster within conference IPEG 2008, Rouffach, France during days 24.-27.10.2008: Palenicek T., Fujakova M., Kutova M., Brunovsky M., Horacek J., Sos P., Tislerova B., Bubenikova-Valesova V. Quantitative EEG in glutamatergic and dopaminergic models of psychosis – animal study
2010: ČNPS award for best clinical manuscript published in 2010: Horacek J, Brunovsky M, Novak T, Tislerova B, Palenicek T, Bubenikova-Valesova V, Spaniel F, Koprivova J, Mohr P, Balikova M, Hoschl C. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect. Psychol Med., 2010; 40(9):1443-51
2010: CINP poster prize award from XXVII CINP Congress, 6 - 10 June 2010, Hong Kong: Páleníček, T., Brunovský, M., Horáček, J., Fujáková, M., Gorman, I., Tylš, F., Krajča, V. The effect of ketamine on sensorimotor gating, EEG spectra and coherence - comparison of human and animal data.
2010: CINP poster prize award from XXVII CINP Congress, 6 - 10 June 2010, Hong Kong: Fujáková, M., Páleníček, T., Brunovský, M., Bubeníková-Valešová, V., Gorman, I. A potential antipsychotic effect of group II metabotropic glutamate receptor agonist, LY379268, on behavioral changes and quantitative electroencephalography in rats in ketamine model of psychosis.

Specialization

2012 - 2012: licensed in Psychiatry

Teaching activities

2001 - present: assistent professor, teaching psychiatry at 3rd Faculty of Medicine, Charles University in Prague (psychiatry, phramcology, drug addiction)
2004: oponent of Tomáš Vejrych´s thesis "Extasy and free techno party"
2005 - 2006: tutor of Michaela Fujáková´s student scientific activity at 1st Faculty of Medicine, Charles University, Prague: "Influence of a Synthetic Drug 2C-B on EEG Spektrum and EEG Coherence in the Rat – A Potential Model of Psychosis?"
2005 - 2008: tutor of Martina Kutová´s thesis on Faculty of Natural Sciences, Charles University in Prague: "The Role of 5-HT1 and 5-HT2 Serotonin Receptors in Mechanism of Synthetic drug 2C-B Effect – Behavioural Study on Rats"
2005 - present: Assistent professor, teaching neurosciences at 1st Faculty of Medicine, Charles University in Prague, branch of addictology
2009 - 2010: tutor of Filip Tylš´s student scientific activity at 1st Faculty of Medicine, Charles University, Prague: "Animal models of psychosis – The role of AMPA glutamatergic receptors in neurobiology of schizophrenia"
2011 - present: tutor of postgradual students in Neurosciences on 3.LFUK

Thesis

2009: The role of dopaminergic and serotonergic neurotransmission in animal models of psychoses

Publications

Most important publications

TYLŠ, F., PÁLENÍČEK, T., HORÁČEK, J. Psilocybin - Summary of knowledge and new perspectives. European Neuropsychopharmacology. 2014, 24(3), 342-356. ISSN 0924-977X. DOI: 10.1016/j.euroneuro.2013.12.006. IF 4.369.

FUJÁKOVÁ, M., PÁLENÍČEK, T., BRUNOVSKÝ, M., GORMAN, I., TYLŠ, F., KUBEŠOVÁ, A., ŘÍPOVÁ, D., KRAJČA, V., HORÁČEK, J. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Pharmacology Biochemistry and Behavior. 2014, 122(July), 212-221. ISSN 0091-3057. DOI: 10.1016/j.pbb.2014.03.001. IF 2.781.

PÁLENÍČEK, T., FUJÁKOVÁ, M., BRUNOVSKÝ, M., HORÁČEK, J., GORMAN, I., BALÍKOVÁ, M., RAMBOUSEK, L., SYSLOVÁ, K., KAČER, P., ZACH, P., BUBENÍKOVÁ-VALEŠOVÁ, V., TYLŠ, F., KUBEŠOVÁ, A., PUSKARČÍKOVÁ, J., HÖSCHL, C. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology. 2013, 225(1), 75-93. ISSN 0033-3158. DOI: 10.1007/s00213-012-2797-7. IF 3.988.

PÁLENÍČEK, T., HLIŇÁK, Z., BUBENÍKOVÁ-VALEŠOVÁ, V., NOVÁK, T., HORÁČEK, J. Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010, 34(4), 588-596. ISSN 0278-5846. DOI: 10.1016/j.pnpbp.2010.02.008. IF 2.877.

PÁLENÍČEK, T., BALÍKOVÁ, M., BUBENÍKOVÁ-VALEŠOVÁ, V., HORÁČEK, J. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology. 2008, 196(1), 51-62. ISSN 0033-3158. DOI: 10.1007/s00213-007-0926-5. IF 3.676.


Show all publications of this employee

Databáze všech publikací NUDZ

 


Profile Organizational Chart How Can I Book an Appointment? Outpatient Clinic Inpatient Ward 1: Anxiety Disorders Inpatient Ward 2: Mood Disorders Inpatient Ward 3: Psychotic Disorders Day Care Center 1: Anxiety and Personality Disorders Day Care Center 2: Anxiety Disorders Day Care Center 3: Psychotic Disorders Dept. of Cognitive Disorders Neurophysiology and EEG Department of Sleep Medicine Neurostimulation Neuroimaging Unit Clinical Psychology Physiotherapy Occupational Therapy Social Services Specific Treatment Programs Medicinal Doctors (Psychiatrists) Sponsorship Patients Rights
About NIMH Czech Rep. Research Programmes Medical Care For Students Information Centre Press Career Contacts